We aimed at evaluating the potential role of PKM, ALDO, FABP3, and UCHL1 as CSF biomarkers useful to characterise the AD continuum and understand the role of metabolic pathways in early AD pathogenesis [16]. This evidence concerns the gene UCHL1 and Alzheimer disease.